Bevacizumab in HER2-negative inflammatory breast cancer - Archive ouverte HAL Access content directly
Journal Articles Oncoscience Year : 2016

Dates and versions

hal-03623723 , version 1 (29-03-2022)

Identifiers

Cite

François Bertucci, Anthony Goncalves, Patrice Viens. Bevacizumab in HER2-negative inflammatory breast cancer. Oncoscience, 2016, 3 (11-12), pp.297-298. ⟨10.18632/oncoscience.324⟩. ⟨hal-03623723⟩
6 View
0 Download

Altmetric

Share

Gmail Facebook Twitter LinkedIn More